CD274 and hepatocellular carcinoma: However, such disappointing phenomena can be rescued by the checkpoint inhibitors of anti‐PD‐1 and anti‐PD‐L1 that have achieved great success in many solid tumors including HCC but are still restricted by low immune response in clinic.